<?xml-stylesheet type="text/xsl" href="https://www.vetsurgeon.org/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New treatment for canine otitis externa coming in the new year</title><link>/b/veterinary-news/posts/new-treatment-for-canine-otitis-externa-coming-in-the-new-year</link><description> Bayer Animal Health has announced that it has been given marketing authorisation in Europe for Neptra (florfenicol, terbinafine hydrochloride, mometasone furoate), a new treatment for canine otitis externa which requires just one dose, administered by</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>